Synthetic studies on mitotic kinesin Eg5 inhibitors: Synthesis and structure-activity relationships of novel 2,4,5-substituted-1,3,4-thiadiazoline derivatives

被引:8
|
作者
Yamamoto, Junichiro [1 ]
Amishiro, Nobuyoshi [1 ]
Kato, Kazuhiko [1 ]
Ohta, Yoshihisa [1 ]
Ino, Yoji [1 ]
Araki, Mitsuharu [1 ]
Tsujita, Tetsuya [1 ]
Okamoto, Seiho [1 ]
Takahashi, Takeshi [1 ]
Kusaka, Hideaki [1 ]
Akinaga, Shiro [1 ]
Yamashita, Yoshinori [1 ]
Nakai, Ryuichiro [1 ]
Murakata, Chikara [1 ]
机构
[1] Kyowa Hakko Kirin Co Ltd, Div Res, Nagaizumi, Shizuoka 4118731, Japan
关键词
Mitotic kinesin Eg5 inhibitor; Thiadiazoline derivatives;
D O I
10.1016/j.bmcl.2014.06.034
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 2,4,5-substituted-1,3,4-thiadiazoline derivative 1a has been identified as a new class of mitotic kinesin Eg5 inhibitor. With the aim of enhancement of the mitotic phase accumulation activity, structure optimization of side chains at the 2-, 4-, and 5-positions of the 1,3,4-thiadiazoline ring of 1a was performed. The introduction of sulfonylamino group at the side chain at the 5-position and bulky acyl group at the 2- and 4-position contributed to a significant increase in the mitotic phase accumulation activity and Eg5 inhibitory activity. As a result, a series of optically active compounds exhibited an increased antitumor activity in a human ovarian cancer xenograft mouse model that was induced by oral administration. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3961 / 3963
页数:3
相关论文
共 50 条
  • [1] Structure-activity relationship of pyrazolo pyrimidine derivatives as inhibitors of mitotic kinesin Eg5 and anticancer agents
    Muthuraja, P.
    Veeramani, V.
    Prakash, S.
    Himesh, M.
    Venkatasubramanian, U.
    Manisankar, P.
    BIOORGANIC CHEMISTRY, 2019, 84 : 493 - 504
  • [2] Structure-Activity Relationships and Molecular Docking of Novel Dihydropyrimidine-Based Mitotic Eg5 Inhibitors
    Prokopcova, Hana
    Dallinger, Doris
    Uray, Georg
    Kaan, Hung Yi Kristal
    Ulaganathan, Venkatasubramanian
    Kozielski, Frank
    Laggner, Christian
    Kappe, C. Oliver
    CHEMMEDCHEM, 2010, 5 (10) : 1760 - 1769
  • [3] A novel class of mitotic kinesin Eg5 inhibitors: Design, synthesis and characterization of L-cysteine derivatives
    Ogo, Naohisa
    Uehara, Yutaka
    Matsuno, Kenji
    Sawada, Jun-Ichi
    Asai, Akira
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3525S - 3525S
  • [4] Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5
    DeBonis, Salvatore
    Skoufias, Dimitrios A.
    Indorato, Rose-Laure
    Liger, Francois
    Marquet, Bernard
    Laggner, Christian
    Joseph, Benoit
    Kozielski, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1115 - 1125
  • [5] 3D-QSAR Studies of Dihydropyrazole and Dihydropyrrole Derivatives as Inhibitors of Human Mitotic Kinesin Eg5 Based on Molecular Docking
    Luo, Xingyan
    Shu, Mao
    Wang, Yuanqiang
    Liu, Jin
    Yang, Wenjuan
    Lin, Zhihua
    MOLECULES, 2012, 17 (02) : 2015 - 2029
  • [6] Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives
    S. I. El-Desoky
    F. A. Badria
    M. A. Abozeid
    E. A. Kandeel
    A. H. Abdel-Rahman
    Medicinal Chemistry Research, 2013, 22 : 2105 - 2114
  • [7] Synthesis and antitumor studies of novel benzopyrano-1,2,3-selenadiazole and spiro[benzopyrano]-1,3,4-thiadiazoline derivatives
    El-Desoky, S. I.
    Badria, F. A.
    Abozeid, M. A.
    Kandeel, E. A.
    Abdel-Rahman, A. H.
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (05) : 2105 - 2114
  • [8] Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure-activity relationships of pyrimidine-5-carboxamide derivatives
    Hisamichi, H
    Naito, R
    Toyoshima, A
    Kawano, N
    Ichikawa, A
    Orita, A
    Orita, M
    Hamada, N
    Takeuchi, M
    Ohta, M
    Tsukamoto, SI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (16) : 4936 - 4951
  • [9] In silico analysis of 3D QSAR and Molecular Docking studies to discover new thiadiazole-thiazolone derivatives as mitotic kinesin Eg5 inhibitors
    El Khatabi, Khalil
    Aanouz, Ilham
    El-mernissi, Reda
    Khaldan, Ayoub
    Ajana, Mohammed Aziz
    Bouachrine, Mohammed
    Lakhlifi, Tahar
    MOROCCAN JOURNAL OF CHEMISTRY, 2021, 9 (03):
  • [10] Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines
    Navarrete-Vazquez, Gabriel
    Molina-Salinas, Gloria Maria
    Duarte-Fajardo, Zetel Vahi
    Vargas-Villarreal, Javier
    Estrada-Soto, Samuel
    Gonzalez-Salazar, Francisco
    Hernandez-Nunez, Emanuel
    Said-Fernandez, Salvador
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (16) : 5502 - 5508